nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—SCN4A—epilepsy syndrome	0.299	0.855	CbGaD
Flecainide—CYP2D6—epilepsy syndrome	0.0509	0.145	CbGaD
Flecainide—SCN4A—Lamotrigine—epilepsy syndrome	0.0437	0.095	CbGbCtD
Flecainide—SCN4A—Rufinamide—epilepsy syndrome	0.0386	0.0839	CbGbCtD
Flecainide—SCN5A—Oxcarbazepine—epilepsy syndrome	0.038	0.0828	CbGbCtD
Flecainide—SCN4A—Carbamazepine—epilepsy syndrome	0.0376	0.0818	CbGbCtD
Flecainide—SCN4A—Phenytoin—epilepsy syndrome	0.0337	0.0734	CbGbCtD
Flecainide—SCN5A—Fosphenytoin—epilepsy syndrome	0.0333	0.0724	CbGbCtD
Flecainide—SCN4A—Propofol—epilepsy syndrome	0.0314	0.0684	CbGbCtD
Flecainide—SCN4A—Zonisamide—epilepsy syndrome	0.0278	0.0605	CbGbCtD
Flecainide—SCN5A—Lamotrigine—epilepsy syndrome	0.0278	0.0604	CbGbCtD
Flecainide—SCN5A—Rufinamide—epilepsy syndrome	0.0245	0.0534	CbGbCtD
Flecainide—SCN5A—Carbamazepine—epilepsy syndrome	0.0239	0.052	CbGbCtD
Flecainide—SCN5A—Phenytoin—epilepsy syndrome	0.0214	0.0466	CbGbCtD
Flecainide—SCN5A—Zonisamide—epilepsy syndrome	0.0177	0.0385	CbGbCtD
Flecainide—SCN5A—Topiramate—epilepsy syndrome	0.0129	0.028	CbGbCtD
Flecainide—CYP2C9—Trimethadione—epilepsy syndrome	0.00739	0.0161	CbGbCtD
Flecainide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00695	0.0151	CbGbCtD
Flecainide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00499	0.0109	CbGbCtD
Flecainide—CYP2C9—Primidone—epilepsy syndrome	0.00466	0.0101	CbGbCtD
Flecainide—CYP2C9—Phenytoin—epilepsy syndrome	0.00448	0.00974	CbGbCtD
Flecainide—CYP2C9—Propofol—epilepsy syndrome	0.00417	0.00909	CbGbCtD
Flecainide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00399	0.00868	CbGbCtD
Flecainide—CYP2D6—Propofol—epilepsy syndrome	0.00382	0.00831	CbGbCtD
Flecainide—CYP2C9—Diazepam—epilepsy syndrome	0.00378	0.00823	CbGbCtD
Flecainide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00298	0.00649	CbGbCtD
Flecainide—Mefloquine—BCHE—epilepsy syndrome	0.00101	0.515	CrCbGaD
Flecainide—Mefloquine—CYP2D6—epilepsy syndrome	0.000553	0.283	CrCbGaD
Flecainide—Mefloquine—ABCB1—epilepsy syndrome	0.000395	0.202	CrCbGaD
Flecainide—SCN4A—Axon guidance—GRIN2B—epilepsy syndrome	5.84e-05	0.00116	CbGpPWpGaD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	5.82e-05	0.00116	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	5.81e-05	0.00116	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	5.79e-05	0.00115	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CNTN2—epilepsy syndrome	5.78e-05	0.00115	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	5.78e-05	0.00115	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	5.77e-05	0.00115	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PRNP—epilepsy syndrome	5.76e-05	0.00115	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	5.74e-05	0.00114	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	5.73e-05	0.00114	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	5.7e-05	0.00114	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	5.69e-05	0.00113	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SLIT2—epilepsy syndrome	5.55e-05	0.0011	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ANK3—epilepsy syndrome	5.55e-05	0.0011	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	5.48e-05	0.00109	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—PRNP—epilepsy syndrome	5.48e-05	0.00109	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CDH2—epilepsy syndrome	5.42e-05	0.00108	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—SRC—epilepsy syndrome	5.4e-05	0.00108	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—APOE—epilepsy syndrome	5.36e-05	0.00107	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CACNA1D—epilepsy syndrome	5.34e-05	0.00106	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	5.3e-05	0.00105	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ADAM10—epilepsy syndrome	5.26e-05	0.00105	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	5.21e-05	0.00104	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GDNF—epilepsy syndrome	5.16e-05	0.00103	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	5.14e-05	0.00102	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	5.12e-05	0.00102	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ACTB—epilepsy syndrome	5.07e-05	0.00101	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	5.06e-05	0.00101	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	5.04e-05	0.001	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SPTAN1—epilepsy syndrome	4.99e-05	0.000994	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ITGA2—epilepsy syndrome	4.98e-05	0.000992	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—CDC42—epilepsy syndrome	4.92e-05	0.000979	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ACTB—epilepsy syndrome	4.82e-05	0.00096	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	4.82e-05	0.000959	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	4.75e-05	0.000945	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ITGA2—epilepsy syndrome	4.74e-05	0.000943	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.72e-05	0.00094	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	4.71e-05	0.000937	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.68e-05	0.000931	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—FYN—epilepsy syndrome	4.38e-05	0.000872	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—DLG4—epilepsy syndrome	4.26e-05	0.000849	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	4.22e-05	0.000841	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GRIN2B—epilepsy syndrome	4.17e-05	0.00083	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TCF4—epilepsy syndrome	4.12e-05	0.000821	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—DLG4—epilepsy syndrome	4.05e-05	0.000806	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—GPX1—epilepsy syndrome	4e-05	0.000796	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—GRIN2B—epilepsy syndrome	3.96e-05	0.000788	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PRNP—epilepsy syndrome	3.91e-05	0.000778	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT3—epilepsy syndrome	3.85e-05	0.000766	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ADAM10—epilepsy syndrome	3.76e-05	0.000748	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CDH2—epilepsy syndrome	3.67e-05	0.000731	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—SRC—epilepsy syndrome	3.66e-05	0.000729	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—KDR—epilepsy syndrome	3.61e-05	0.000718	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ADAM10—epilepsy syndrome	3.57e-05	0.00071	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CDC42—epilepsy syndrome	3.51e-05	0.000699	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6ST—epilepsy syndrome	3.46e-05	0.000689	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ACTB—epilepsy syndrome	3.44e-05	0.000685	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ITGA2—epilepsy syndrome	3.38e-05	0.000673	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—CDC42—epilepsy syndrome	3.33e-05	0.000664	CbGpPWpGaD
Flecainide—Rash—Vigabatrin—epilepsy syndrome	3.27e-05	0.000236	CcSEcCtD
Flecainide—Dizziness—Felbamate—epilepsy syndrome	3.27e-05	0.000236	CcSEcCtD
Flecainide—Dermatitis—Vigabatrin—epilepsy syndrome	3.27e-05	0.000236	CcSEcCtD
Flecainide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.26e-05	0.000235	CcSEcCtD
Flecainide—Convulsion—Pregabalin—epilepsy syndrome	3.26e-05	0.000235	CcSEcCtD
Flecainide—Vision blurred—Gabapentin—epilepsy syndrome	3.25e-05	0.000235	CcSEcCtD
Flecainide—Headache—Vigabatrin—epilepsy syndrome	3.25e-05	0.000235	CcSEcCtD
Flecainide—Hypertension—Pregabalin—epilepsy syndrome	3.25e-05	0.000234	CcSEcCtD
Flecainide—Vomiting—Diazepam—epilepsy syndrome	3.25e-05	0.000234	CcSEcCtD
Flecainide—Anorexia—Valproic Acid—epilepsy syndrome	3.24e-05	0.000234	CcSEcCtD
Flecainide—Tremor—Gabapentin—epilepsy syndrome	3.23e-05	0.000233	CcSEcCtD
Flecainide—Rash—Diazepam—epilepsy syndrome	3.22e-05	0.000233	CcSEcCtD
Flecainide—Dermatitis—Diazepam—epilepsy syndrome	3.22e-05	0.000232	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—HES1—epilepsy syndrome	3.21e-05	0.00064	CbGpPWpGaD
Flecainide—Visual impairment—Topiramate—epilepsy syndrome	3.21e-05	0.000232	CcSEcCtD
Flecainide—Arthralgia—Pregabalin—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Flecainide—Myalgia—Pregabalin—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Flecainide—Chest pain—Pregabalin—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Flecainide—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Flecainide—Dizziness—Zonisamide—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Flecainide—Headache—Diazepam—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Flecainide—Anxiety—Pregabalin—epilepsy syndrome	3.19e-05	0.00023	CcSEcCtD
Flecainide—Diarrhoea—Clonazepam—epilepsy syndrome	3.19e-05	0.00023	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.18e-05	0.00023	CcSEcCtD
Flecainide—Hypotension—Valproic Acid—epilepsy syndrome	3.17e-05	0.000229	CcSEcCtD
Flecainide—Asthenia—Carbamazepine—epilepsy syndrome	3.17e-05	0.000229	CcSEcCtD
Flecainide—Diarrhoea—Phenytoin—epilepsy syndrome	3.17e-05	0.000229	CcSEcCtD
Flecainide—Discomfort—Pregabalin—epilepsy syndrome	3.16e-05	0.000228	CcSEcCtD
Flecainide—Nausea—Fosphenytoin—epilepsy syndrome	3.16e-05	0.000228	CcSEcCtD
Flecainide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000228	CcSEcCtD
Flecainide—Vomiting—Felbamate—epilepsy syndrome	3.14e-05	0.000227	CcSEcCtD
Flecainide—Dry mouth—Pregabalin—epilepsy syndrome	3.13e-05	0.000226	CcSEcCtD
Flecainide—Pruritus—Carbamazepine—epilepsy syndrome	3.13e-05	0.000226	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—FYN—epilepsy syndrome	3.12e-05	0.000622	CbGpPWpGaD
Flecainide—Rash—Felbamate—epilepsy syndrome	3.12e-05	0.000225	CcSEcCtD
Flecainide—Eye disorder—Topiramate—epilepsy syndrome	3.11e-05	0.000225	CcSEcCtD
Flecainide—Dermatitis—Felbamate—epilepsy syndrome	3.11e-05	0.000225	CcSEcCtD
Flecainide—Malaise—Gabapentin—epilepsy syndrome	3.11e-05	0.000225	CcSEcCtD
Flecainide—Tinnitus—Topiramate—epilepsy syndrome	3.11e-05	0.000224	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—MEF2C—epilepsy syndrome	3.11e-05	0.000619	CbGpPWpGaD
Flecainide—Vertigo—Gabapentin—epilepsy syndrome	3.1e-05	0.000224	CcSEcCtD
Flecainide—Headache—Felbamate—epilepsy syndrome	3.1e-05	0.000224	CcSEcCtD
Flecainide—Confusional state—Pregabalin—epilepsy syndrome	3.1e-05	0.000224	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.09e-05	0.000223	CcSEcCtD
Flecainide—Flushing—Topiramate—epilepsy syndrome	3.09e-05	0.000223	CcSEcCtD
Flecainide—Syncope—Gabapentin—epilepsy syndrome	3.09e-05	0.000223	CcSEcCtD
Flecainide—Leukopenia—Gabapentin—epilepsy syndrome	3.09e-05	0.000223	CcSEcCtD
Flecainide—Dizziness—Clonazepam—epilepsy syndrome	3.08e-05	0.000223	CcSEcCtD
Flecainide—Nausea—Vigabatrin—epilepsy syndrome	3.08e-05	0.000222	CcSEcCtD
Flecainide—Vomiting—Zonisamide—epilepsy syndrome	3.08e-05	0.000222	CcSEcCtD
Flecainide—Insomnia—Valproic Acid—epilepsy syndrome	3.07e-05	0.000222	CcSEcCtD
Flecainide—Oedema—Pregabalin—epilepsy syndrome	3.07e-05	0.000222	CcSEcCtD
Flecainide—Asthenia—Lamotrigine—epilepsy syndrome	3.07e-05	0.000221	CcSEcCtD
Flecainide—Dizziness—Phenytoin—epilepsy syndrome	3.06e-05	0.000221	CcSEcCtD
Flecainide—Rash—Zonisamide—epilepsy syndrome	3.05e-05	0.00022	CcSEcCtD
Flecainide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.05e-05	0.00022	CcSEcCtD
Flecainide—Palpitations—Gabapentin—epilepsy syndrome	3.05e-05	0.00022	CcSEcCtD
Flecainide—Dermatitis—Zonisamide—epilepsy syndrome	3.05e-05	0.00022	CcSEcCtD
Flecainide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.05e-05	0.00022	CcSEcCtD
Flecainide—Nausea—Diazepam—epilepsy syndrome	3.03e-05	0.000219	CcSEcCtD
Flecainide—Loss of consciousness—Gabapentin—epilepsy syndrome	3.03e-05	0.000219	CcSEcCtD
Flecainide—Headache—Zonisamide—epilepsy syndrome	3.03e-05	0.000219	CcSEcCtD
Flecainide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.03e-05	0.000219	CcSEcCtD
Flecainide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.02e-05	0.000218	CcSEcCtD
Flecainide—Pruritus—Lamotrigine—epilepsy syndrome	3.02e-05	0.000218	CcSEcCtD
Flecainide—Shock—Pregabalin—epilepsy syndrome	3.02e-05	0.000218	CcSEcCtD
Flecainide—Somnolence—Valproic Acid—epilepsy syndrome	3.02e-05	0.000218	CcSEcCtD
Flecainide—Immune system disorder—Topiramate—epilepsy syndrome	3.01e-05	0.000217	CcSEcCtD
Flecainide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.01e-05	0.000217	CcSEcCtD
Flecainide—Cough—Gabapentin—epilepsy syndrome	3.01e-05	0.000217	CcSEcCtD
Flecainide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.01e-05	0.000217	CcSEcCtD
Flecainide—Tachycardia—Pregabalin—epilepsy syndrome	3e-05	0.000216	CcSEcCtD
Flecainide—Dyspepsia—Valproic Acid—epilepsy syndrome	2.99e-05	0.000216	CcSEcCtD
Flecainide—Convulsion—Gabapentin—epilepsy syndrome	2.99e-05	0.000216	CcSEcCtD
Flecainide—Skin disorder—Pregabalin—epilepsy syndrome	2.98e-05	0.000215	CcSEcCtD
Flecainide—Hypertension—Gabapentin—epilepsy syndrome	2.98e-05	0.000215	CcSEcCtD
Flecainide—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.97e-05	0.000214	CcSEcCtD
Flecainide—SCN5A—Axon guidance—FYN—epilepsy syndrome	2.97e-05	0.000591	CbGpPWpGaD
Flecainide—Vomiting—Clonazepam—epilepsy syndrome	2.96e-05	0.000214	CcSEcCtD
Flecainide—Decreased appetite—Valproic Acid—epilepsy syndrome	2.95e-05	0.000213	CcSEcCtD
Flecainide—Alopecia—Topiramate—epilepsy syndrome	2.95e-05	0.000213	CcSEcCtD
Flecainide—Vomiting—Phenytoin—epilepsy syndrome	2.94e-05	0.000213	CcSEcCtD
Flecainide—Rash—Clonazepam—epilepsy syndrome	2.94e-05	0.000212	CcSEcCtD
Flecainide—Dermatitis—Clonazepam—epilepsy syndrome	2.94e-05	0.000212	CcSEcCtD
Flecainide—Myalgia—Gabapentin—epilepsy syndrome	2.94e-05	0.000212	CcSEcCtD
Flecainide—Arthralgia—Gabapentin—epilepsy syndrome	2.94e-05	0.000212	CcSEcCtD
Flecainide—Chest pain—Gabapentin—epilepsy syndrome	2.94e-05	0.000212	CcSEcCtD
Flecainide—Nausea—Felbamate—epilepsy syndrome	2.94e-05	0.000212	CcSEcCtD
Flecainide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.93e-05	0.000212	CcSEcCtD
Flecainide—Vomiting—Oxcarbazepine—epilepsy syndrome	2.93e-05	0.000212	CcSEcCtD
Flecainide—Fatigue—Valproic Acid—epilepsy syndrome	2.93e-05	0.000211	CcSEcCtD
Flecainide—Anxiety—Gabapentin—epilepsy syndrome	2.93e-05	0.000211	CcSEcCtD
Flecainide—Anorexia—Pregabalin—epilepsy syndrome	2.93e-05	0.000211	CcSEcCtD
Flecainide—Dizziness—Carbamazepine—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Flecainide—Diarrhoea—Lamotrigine—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Flecainide—Headache—Clonazepam—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Flecainide—Rash—Phenytoin—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Flecainide—Dermatitis—Phenytoin—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	2.91e-05	0.00058	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	2.91e-05	0.00058	CbGpPWpGaD
Flecainide—Rash—Oxcarbazepine—epilepsy syndrome	2.9e-05	0.00021	CcSEcCtD
Flecainide—Pain—Valproic Acid—epilepsy syndrome	2.9e-05	0.00021	CcSEcCtD
Flecainide—Constipation—Valproic Acid—epilepsy syndrome	2.9e-05	0.00021	CcSEcCtD
Flecainide—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.9e-05	0.00021	CcSEcCtD
Flecainide—Headache—Phenytoin—epilepsy syndrome	2.9e-05	0.00021	CcSEcCtD
Flecainide—Discomfort—Gabapentin—epilepsy syndrome	2.9e-05	0.000209	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—DLG4—epilepsy syndrome	2.89e-05	0.000575	CbGpPWpGaD
Flecainide—Headache—Oxcarbazepine—epilepsy syndrome	2.89e-05	0.000208	CcSEcCtD
Flecainide—Nausea—Zonisamide—epilepsy syndrome	2.87e-05	0.000208	CcSEcCtD
Flecainide—Dry mouth—Gabapentin—epilepsy syndrome	2.87e-05	0.000207	CcSEcCtD
Flecainide—Hypotension—Pregabalin—epilepsy syndrome	2.87e-05	0.000207	CcSEcCtD
Flecainide—Flatulence—Topiramate—epilepsy syndrome	2.86e-05	0.000206	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.86e-05	0.000569	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.85e-05	0.000567	CbGpPWpGaD
Flecainide—Tension—Topiramate—epilepsy syndrome	2.85e-05	0.000206	CcSEcCtD
Flecainide—Dysgeusia—Topiramate—epilepsy syndrome	2.84e-05	0.000205	CcSEcCtD
Flecainide—Confusional state—Gabapentin—epilepsy syndrome	2.84e-05	0.000205	CcSEcCtD
Flecainide—Dizziness—Lamotrigine—epilepsy syndrome	2.83e-05	0.000204	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—GRIN2B—epilepsy syndrome	2.82e-05	0.000562	CbGpPWpGaD
Flecainide—Nervousness—Topiramate—epilepsy syndrome	2.82e-05	0.000204	CcSEcCtD
Flecainide—Oedema—Gabapentin—epilepsy syndrome	2.81e-05	0.000203	CcSEcCtD
Flecainide—Vomiting—Carbamazepine—epilepsy syndrome	2.81e-05	0.000203	CcSEcCtD
Flecainide—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.8e-05	0.000202	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.8e-05	0.000202	CcSEcCtD
Flecainide—Rash—Carbamazepine—epilepsy syndrome	2.79e-05	0.000201	CcSEcCtD
Flecainide—Dermatitis—Carbamazepine—epilepsy syndrome	2.78e-05	0.000201	CcSEcCtD
Flecainide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.78e-05	0.0002	CcSEcCtD
Flecainide—Insomnia—Pregabalin—epilepsy syndrome	2.78e-05	0.0002	CcSEcCtD
Flecainide—Nausea—Clonazepam—epilepsy syndrome	2.77e-05	0.0002	CcSEcCtD
Flecainide—Headache—Carbamazepine—epilepsy syndrome	2.77e-05	0.0002	CcSEcCtD
Flecainide—Shock—Gabapentin—epilepsy syndrome	2.77e-05	0.0002	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.77e-05	0.000551	CbGpPWpGaD
Flecainide—Nervous system disorder—Gabapentin—epilepsy syndrome	2.76e-05	0.000199	CcSEcCtD
Flecainide—Paraesthesia—Pregabalin—epilepsy syndrome	2.76e-05	0.000199	CcSEcCtD
Flecainide—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.76e-05	0.000199	CcSEcCtD
Flecainide—Nausea—Phenytoin—epilepsy syndrome	2.75e-05	0.000199	CcSEcCtD
Flecainide—Tachycardia—Gabapentin—epilepsy syndrome	2.75e-05	0.000198	CcSEcCtD
Flecainide—Dyspnoea—Pregabalin—epilepsy syndrome	2.74e-05	0.000198	CcSEcCtD
Flecainide—Nausea—Oxcarbazepine—epilepsy syndrome	2.74e-05	0.000198	CcSEcCtD
Flecainide—Vision blurred—Topiramate—epilepsy syndrome	2.73e-05	0.000197	CcSEcCtD
Flecainide—Skin disorder—Gabapentin—epilepsy syndrome	2.73e-05	0.000197	CcSEcCtD
Flecainide—Somnolence—Pregabalin—epilepsy syndrome	2.73e-05	0.000197	CcSEcCtD
Flecainide—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.72e-05	0.000196	CcSEcCtD
Flecainide—Tremor—Topiramate—epilepsy syndrome	2.72e-05	0.000196	CcSEcCtD
Flecainide—Vomiting—Lamotrigine—epilepsy syndrome	2.72e-05	0.000196	CcSEcCtD
Flecainide—Urticaria—Valproic Acid—epilepsy syndrome	2.7e-05	0.000195	CcSEcCtD
Flecainide—Rash—Lamotrigine—epilepsy syndrome	2.69e-05	0.000195	CcSEcCtD
Flecainide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.69e-05	0.000194	CcSEcCtD
Flecainide—Dermatitis—Lamotrigine—epilepsy syndrome	2.69e-05	0.000194	CcSEcCtD
Flecainide—Abdominal pain—Valproic Acid—epilepsy syndrome	2.68e-05	0.000194	CcSEcCtD
Flecainide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.68e-05	0.000194	CcSEcCtD
Flecainide—Anorexia—Gabapentin—epilepsy syndrome	2.68e-05	0.000194	CcSEcCtD
Flecainide—Headache—Lamotrigine—epilepsy syndrome	2.68e-05	0.000193	CcSEcCtD
Flecainide—Decreased appetite—Pregabalin—epilepsy syndrome	2.67e-05	0.000193	CcSEcCtD
Flecainide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.65e-05	0.000191	CcSEcCtD
Flecainide—Fatigue—Pregabalin—epilepsy syndrome	2.65e-05	0.000191	CcSEcCtD
Flecainide—Hypotension—Gabapentin—epilepsy syndrome	2.63e-05	0.00019	CcSEcCtD
Flecainide—Nausea—Carbamazepine—epilepsy syndrome	2.63e-05	0.00019	CcSEcCtD
Flecainide—Constipation—Pregabalin—epilepsy syndrome	2.62e-05	0.00019	CcSEcCtD
Flecainide—Pain—Pregabalin—epilepsy syndrome	2.62e-05	0.00019	CcSEcCtD
Flecainide—Malaise—Topiramate—epilepsy syndrome	2.62e-05	0.000189	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—AKT3—epilepsy syndrome	2.61e-05	0.000519	CbGpPWpGaD
Flecainide—Vertigo—Topiramate—epilepsy syndrome	2.61e-05	0.000188	CcSEcCtD
Flecainide—Syncope—Topiramate—epilepsy syndrome	2.6e-05	0.000188	CcSEcCtD
Flecainide—Leukopenia—Topiramate—epilepsy syndrome	2.6e-05	0.000188	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—KDR—epilepsy syndrome	2.57e-05	0.000513	CbGpPWpGaD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.57e-05	0.000512	CbGpPWpGaD
Flecainide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.56e-05	0.000185	CcSEcCtD
Flecainide—Palpitations—Topiramate—epilepsy syndrome	2.56e-05	0.000185	CcSEcCtD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.55e-05	0.000508	CbGpPWpGaD
Flecainide—Loss of consciousness—Topiramate—epilepsy syndrome	2.55e-05	0.000184	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—ADAM10—epilepsy syndrome	2.55e-05	0.000507	CbGpPWpGaD
Flecainide—Insomnia—Gabapentin—epilepsy syndrome	2.55e-05	0.000184	CcSEcCtD
Flecainide—Nausea—Lamotrigine—epilepsy syndrome	2.54e-05	0.000183	CcSEcCtD
Flecainide—Cough—Topiramate—epilepsy syndrome	2.53e-05	0.000183	CcSEcCtD
Flecainide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.53e-05	0.000183	CcSEcCtD
Flecainide—Paraesthesia—Gabapentin—epilepsy syndrome	2.53e-05	0.000183	CcSEcCtD
Flecainide—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	2.52e-05	0.000502	CbGpPWpGaD
Flecainide—Convulsion—Topiramate—epilepsy syndrome	2.51e-05	0.000182	CcSEcCtD
Flecainide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.51e-05	0.000181	CcSEcCtD
Flecainide—Dyspnoea—Gabapentin—epilepsy syndrome	2.51e-05	0.000181	CcSEcCtD
Flecainide—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	2.51e-05	0.000499	CbGpPWpGaD
Flecainide—Hypertension—Topiramate—epilepsy syndrome	2.51e-05	0.000181	CcSEcCtD
Flecainide—Somnolence—Gabapentin—epilepsy syndrome	2.5e-05	0.000181	CcSEcCtD
Flecainide—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	2.5e-05	0.000498	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.49e-05	0.000495	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	2.48e-05	0.000495	CbGpPWpGaD
Flecainide—Dyspepsia—Gabapentin—epilepsy syndrome	2.48e-05	0.000179	CcSEcCtD
Flecainide—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.47e-05	0.000492	CbGpPWpGaD
Flecainide—Myalgia—Topiramate—epilepsy syndrome	2.47e-05	0.000178	CcSEcCtD
Flecainide—Chest pain—Topiramate—epilepsy syndrome	2.47e-05	0.000178	CcSEcCtD
Flecainide—Arthralgia—Topiramate—epilepsy syndrome	2.47e-05	0.000178	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—IL6ST—epilepsy syndrome	2.47e-05	0.000491	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.47e-05	0.000491	CbGpPWpGaD
Flecainide—Anxiety—Topiramate—epilepsy syndrome	2.46e-05	0.000178	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.45e-05	0.000177	CcSEcCtD
Flecainide—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.45e-05	0.000488	CbGpPWpGaD
Flecainide—Decreased appetite—Gabapentin—epilepsy syndrome	2.45e-05	0.000177	CcSEcCtD
Flecainide—SCN5A—Axon guidance—KDR—epilepsy syndrome	2.45e-05	0.000487	CbGpPWpGaD
Flecainide—Discomfort—Topiramate—epilepsy syndrome	2.44e-05	0.000176	CcSEcCtD
Flecainide—Urticaria—Pregabalin—epilepsy syndrome	2.44e-05	0.000176	CcSEcCtD
Flecainide—Asthenia—Valproic Acid—epilepsy syndrome	2.44e-05	0.000176	CcSEcCtD
Flecainide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.43e-05	0.000175	CcSEcCtD
Flecainide—Fatigue—Gabapentin—epilepsy syndrome	2.43e-05	0.000175	CcSEcCtD
Flecainide—Abdominal pain—Pregabalin—epilepsy syndrome	2.43e-05	0.000175	CcSEcCtD
Flecainide—Body temperature increased—Pregabalin—epilepsy syndrome	2.43e-05	0.000175	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.42e-05	0.000481	CbGpPWpGaD
Flecainide—Dry mouth—Topiramate—epilepsy syndrome	2.42e-05	0.000174	CcSEcCtD
Flecainide—Constipation—Gabapentin—epilepsy syndrome	2.41e-05	0.000174	CcSEcCtD
Flecainide—Pain—Gabapentin—epilepsy syndrome	2.41e-05	0.000174	CcSEcCtD
Flecainide—Pruritus—Valproic Acid—epilepsy syndrome	2.4e-05	0.000173	CcSEcCtD
Flecainide—Confusional state—Topiramate—epilepsy syndrome	2.39e-05	0.000172	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—CDC42—epilepsy syndrome	2.38e-05	0.000474	CbGpPWpGaD
Flecainide—Oedema—Topiramate—epilepsy syndrome	2.37e-05	0.000171	CcSEcCtD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.35e-05	0.000469	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6ST—epilepsy syndrome	2.34e-05	0.000467	CbGpPWpGaD
Flecainide—Shock—Topiramate—epilepsy syndrome	2.33e-05	0.000168	CcSEcCtD
Flecainide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.32e-05	0.000168	CcSEcCtD
Flecainide—Nervous system disorder—Topiramate—epilepsy syndrome	2.32e-05	0.000168	CcSEcCtD
Flecainide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.32e-05	0.000167	CcSEcCtD
Flecainide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.32e-05	0.000167	CcSEcCtD
Flecainide—Tachycardia—Topiramate—epilepsy syndrome	2.31e-05	0.000167	CcSEcCtD
Flecainide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.3e-05	0.000166	CcSEcCtD
Flecainide—Skin disorder—Topiramate—epilepsy syndrome	2.3e-05	0.000166	CcSEcCtD
Flecainide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.29e-05	0.000165	CcSEcCtD
Flecainide—Anorexia—Topiramate—epilepsy syndrome	2.26e-05	0.000163	CcSEcCtD
Flecainide—Dizziness—Valproic Acid—epilepsy syndrome	2.25e-05	0.000162	CcSEcCtD
Flecainide—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	2.24e-05	0.000447	CbGpPWpGaD
Flecainide—Urticaria—Gabapentin—epilepsy syndrome	2.24e-05	0.000161	CcSEcCtD
Flecainide—Abdominal pain—Gabapentin—epilepsy syndrome	2.23e-05	0.000161	CcSEcCtD
Flecainide—Body temperature increased—Gabapentin—epilepsy syndrome	2.23e-05	0.000161	CcSEcCtD
Flecainide—SCN4A—Axon guidance—MMP9—epilepsy syndrome	2.21e-05	0.000441	CbGpPWpGaD
Flecainide—Hypotension—Topiramate—epilepsy syndrome	2.21e-05	0.00016	CcSEcCtD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.21e-05	0.00044	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.21e-05	0.000439	CbGpPWpGaD
Flecainide—Asthenia—Pregabalin—epilepsy syndrome	2.2e-05	0.000159	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—HES1—epilepsy syndrome	2.18e-05	0.000434	CbGpPWpGaD
Flecainide—Pruritus—Pregabalin—epilepsy syndrome	2.17e-05	0.000157	CcSEcCtD
Flecainide—Vomiting—Valproic Acid—epilepsy syndrome	2.16e-05	0.000156	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.16e-05	0.000156	CcSEcCtD
Flecainide—Insomnia—Topiramate—epilepsy syndrome	2.14e-05	0.000155	CcSEcCtD
Flecainide—Rash—Valproic Acid—epilepsy syndrome	2.14e-05	0.000155	CcSEcCtD
Flecainide—Dermatitis—Valproic Acid—epilepsy syndrome	2.14e-05	0.000154	CcSEcCtD
Flecainide—Headache—Valproic Acid—epilepsy syndrome	2.13e-05	0.000154	CcSEcCtD
Flecainide—Paraesthesia—Topiramate—epilepsy syndrome	2.13e-05	0.000154	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—FYN—epilepsy syndrome	2.12e-05	0.000422	CbGpPWpGaD
Flecainide—Dyspnoea—Topiramate—epilepsy syndrome	2.11e-05	0.000152	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—MEF2C—epilepsy syndrome	2.11e-05	0.000419	CbGpPWpGaD
Flecainide—Somnolence—Topiramate—epilepsy syndrome	2.11e-05	0.000152	CcSEcCtD
Flecainide—Diarrhoea—Pregabalin—epilepsy syndrome	2.1e-05	0.000152	CcSEcCtD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.09e-05	0.000415	CbGpPWpGaD
Flecainide—Dyspepsia—Topiramate—epilepsy syndrome	2.08e-05	0.000151	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.07e-05	0.000413	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.07e-05	0.000412	CbGpPWpGaD
Flecainide—Decreased appetite—Topiramate—epilepsy syndrome	2.06e-05	0.000149	CcSEcCtD
Flecainide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.04e-05	0.000148	CcSEcCtD
Flecainide—Fatigue—Topiramate—epilepsy syndrome	2.04e-05	0.000147	CcSEcCtD
Flecainide—SCN4A—Axon guidance—SRC—epilepsy syndrome	2.04e-05	0.000406	CbGpPWpGaD
Flecainide—Dizziness—Pregabalin—epilepsy syndrome	2.03e-05	0.000147	CcSEcCtD
Flecainide—Pain—Topiramate—epilepsy syndrome	2.02e-05	0.000146	CcSEcCtD
Flecainide—Constipation—Topiramate—epilepsy syndrome	2.02e-05	0.000146	CcSEcCtD
Flecainide—Asthenia—Gabapentin—epilepsy syndrome	2.02e-05	0.000146	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.02e-05	0.000402	CbGpPWpGaD
Flecainide—Nausea—Valproic Acid—epilepsy syndrome	2.02e-05	0.000146	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—FGF2—epilepsy syndrome	2e-05	0.000397	CbGpPWpGaD
Flecainide—Pruritus—Gabapentin—epilepsy syndrome	1.99e-05	0.000144	CcSEcCtD
Flecainide—SCN4A—Axon guidance—VEGFA—epilepsy syndrome	1.99e-05	0.000396	CbGpPWpGaD
Flecainide—Vomiting—Pregabalin—epilepsy syndrome	1.95e-05	0.000141	CcSEcCtD
Flecainide—Feeling abnormal—Topiramate—epilepsy syndrome	1.95e-05	0.000141	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.94e-05	0.000387	CbGpPWpGaD
Flecainide—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.94e-05	0.00014	CcSEcCtD
Flecainide—Rash—Pregabalin—epilepsy syndrome	1.94e-05	0.00014	CcSEcCtD
Flecainide—Dermatitis—Pregabalin—epilepsy syndrome	1.93e-05	0.00014	CcSEcCtD
Flecainide—Diarrhoea—Gabapentin—epilepsy syndrome	1.93e-05	0.000139	CcSEcCtD
Flecainide—Headache—Pregabalin—epilepsy syndrome	1.92e-05	0.000139	CcSEcCtD
Flecainide—Urticaria—Topiramate—epilepsy syndrome	1.88e-05	0.000136	CcSEcCtD
Flecainide—Abdominal pain—Topiramate—epilepsy syndrome	1.87e-05	0.000135	CcSEcCtD
Flecainide—Body temperature increased—Topiramate—epilepsy syndrome	1.87e-05	0.000135	CcSEcCtD
Flecainide—Dizziness—Gabapentin—epilepsy syndrome	1.86e-05	0.000134	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—RELA—epilepsy syndrome	1.85e-05	0.000369	CbGpPWpGaD
Flecainide—Nausea—Pregabalin—epilepsy syndrome	1.82e-05	0.000132	CcSEcCtD
Flecainide—Vomiting—Gabapentin—epilepsy syndrome	1.79e-05	0.000129	CcSEcCtD
Flecainide—Rash—Gabapentin—epilepsy syndrome	1.77e-05	0.000128	CcSEcCtD
Flecainide—Dermatitis—Gabapentin—epilepsy syndrome	1.77e-05	0.000128	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.76e-05	0.000351	CbGpPWpGaD
Flecainide—Headache—Gabapentin—epilepsy syndrome	1.76e-05	0.000127	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—KDR—epilepsy syndrome	1.75e-05	0.000347	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CA13—epilepsy syndrome	1.73e-05	0.000344	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CA13—epilepsy syndrome	1.71e-05	0.000341	CbGpPWpGaD
Flecainide—Asthenia—Topiramate—epilepsy syndrome	1.7e-05	0.000123	CcSEcCtD
Flecainide—Pruritus—Topiramate—epilepsy syndrome	1.68e-05	0.000121	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—IL6ST—epilepsy syndrome	1.67e-05	0.000333	CbGpPWpGaD
Flecainide—Nausea—Gabapentin—epilepsy syndrome	1.67e-05	0.000121	CcSEcCtD
Flecainide—Diarrhoea—Topiramate—epilepsy syndrome	1.62e-05	0.000117	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—MMP9—epilepsy syndrome	1.58e-05	0.000314	CbGpPWpGaD
Flecainide—Dizziness—Topiramate—epilepsy syndrome	1.57e-05	0.000113	CcSEcCtD
Flecainide—Vomiting—Topiramate—epilepsy syndrome	1.51e-05	0.000109	CcSEcCtD
Flecainide—SCN5A—Axon guidance—MMP9—epilepsy syndrome	1.5e-05	0.000299	CbGpPWpGaD
Flecainide—Rash—Topiramate—epilepsy syndrome	1.49e-05	0.000108	CcSEcCtD
Flecainide—Dermatitis—Topiramate—epilepsy syndrome	1.49e-05	0.000108	CcSEcCtD
Flecainide—Headache—Topiramate—epilepsy syndrome	1.48e-05	0.000107	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—SRC—epilepsy syndrome	1.46e-05	0.00029	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—VEGFA—epilepsy syndrome	1.42e-05	0.000282	CbGpPWpGaD
Flecainide—Nausea—Topiramate—epilepsy syndrome	1.41e-05	0.000102	CcSEcCtD
Flecainide—SCN5A—Axon guidance—SRC—epilepsy syndrome	1.38e-05	0.000275	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.38e-05	0.000274	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	1.35e-05	0.000269	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	1.35e-05	0.000268	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CERS1—epilepsy syndrome	1.31e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PDXK—epilepsy syndrome	1.31e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADK—epilepsy syndrome	1.31e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FAR1—epilepsy syndrome	1.31e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	1.31e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	1.31e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.3e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.3e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.3e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.3e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.3e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.3e-05	0.000258	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—RELA—epilepsy syndrome	1.26e-05	0.00025	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—epilepsy syndrome	1.22e-05	0.000242	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PNPO—epilepsy syndrome	1.2e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	1.2e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GAMT—epilepsy syndrome	1.2e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	1.2e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.19e-05	0.000236	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.19e-05	0.000236	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.19e-05	0.000236	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.19e-05	0.000236	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.11e-05	0.000221	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CA4—epilepsy syndrome	1.11e-05	0.000221	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.11e-05	0.000221	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.1e-05	0.000219	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.1e-05	0.000219	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.1e-05	0.000219	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	1.07e-05	0.000213	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.05e-05	0.000208	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.04e-05	0.000206	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	9.91e-06	0.000197	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	9.91e-06	0.000197	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	9.91e-06	0.000197	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PFKL—epilepsy syndrome	9.91e-06	0.000197	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	9.91e-06	0.000197	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SRC—epilepsy syndrome	9.87e-06	0.000197	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	9.82e-06	0.000196	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	9.82e-06	0.000196	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	9.82e-06	0.000196	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	9.82e-06	0.000196	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	9.82e-06	0.000196	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	9.61e-06	0.000191	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.6e-06	0.000191	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.54e-06	0.00019	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	9.06e-06	0.00018	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	9.06e-06	0.00018	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	9.06e-06	0.00018	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—epilepsy syndrome	9.05e-06	0.00018	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	8.98e-06	0.000179	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	8.98e-06	0.000179	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	8.98e-06	0.000179	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	8.72e-06	0.000174	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	8.65e-06	0.000172	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	8.43e-06	0.000168	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	8.43e-06	0.000168	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	8.35e-06	0.000166	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	8.35e-06	0.000166	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—epilepsy syndrome	8.24e-06	0.000164	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.16e-06	0.000163	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	7.92e-06	0.000158	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	7.85e-06	0.000156	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.71e-06	0.000153	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	7.64e-06	0.000152	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.51e-06	0.00015	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.51e-06	0.00015	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	7.44e-06	0.000148	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	7.44e-06	0.000148	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.16e-06	0.000143	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.16e-06	0.000143	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.1e-06	0.000141	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.1e-06	0.000141	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.01e-06	0.00014	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.95e-06	0.000138	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.87e-06	0.000137	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.81e-06	0.000136	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.74e-06	0.000134	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.68e-06	0.000133	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.61e-06	0.000132	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.55e-06	0.000131	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.18e-06	0.000123	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	6.13e-06	0.000122	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.13e-06	0.000122	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6e-06	0.00012	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.95e-06	0.000119	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.72e-06	0.000114	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.43e-06	0.000108	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.43e-06	0.000108	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.38e-06	0.000107	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.38e-06	0.000107	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.01e-06	9.98e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.91e-06	9.78e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.43e-06	8.81e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.39e-06	8.74e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.31e-06	8.59e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.29e-06	8.54e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.28e-06	8.51e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.25e-06	8.46e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.22e-06	8.4e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.85e-06	7.66e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.84e-06	7.64e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.68e-06	7.33e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.67e-06	7.3e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.65e-06	7.27e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.64e-06	7.24e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.5e-06	6.97e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.47e-06	6.91e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.46e-06	6.89e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TH—epilepsy syndrome	3.45e-06	6.87e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.43e-06	6.83e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TH—epilepsy syndrome	3.42e-06	6.81e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.37e-06	6.7e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.88e-06	5.73e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.85e-06	5.68e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.84e-06	5.65e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.82e-06	5.6e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.76e-06	5.5e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.74e-06	5.45e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.57e-06	5.11e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.55e-06	5.07e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.25e-06	4.48e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.23e-06	4.44e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.21e-06	4.39e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.19e-06	4.36e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.9e-06	3.77e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.88e-06	3.74e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.73e-06	3.44e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.71e-06	3.41e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.51e-06	3.01e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.5e-06	2.98e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.6e-07	1.51e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.53e-07	1.5e-05	CbGpPWpGaD
